Cargando…
Current state of rare disease registries and databases in Australia: a scoping review
BACKGROUND: Rare diseases (RDs) affect approximately 8% of all people or > 400 million people globally. The Australian Government’s National Strategic Action Plan for Rare Diseases has identified the need for a national, coordinated, and systematic approach to the collection and use of RD data, i...
Autores principales: | Ruseckaite, Rasa, Mudunna, Chethana, Caruso, Marisa, Helwani, Falak, Millis, Nicole, Lacaze, Paul, Ahern, Susannah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373259/ https://www.ncbi.nlm.nih.gov/pubmed/37501152 http://dx.doi.org/10.1186/s13023-023-02823-1 |
Ejemplares similares
-
Informing a national rare disease registry strategy in Australia: a mixed methods study
por: Ruseckaite, Rasa, et al.
Publicado: (2023) -
Response rates in clinical quality registries and databases that collect patient reported outcome measures: a scoping review
por: Ruseckaite, Rasa, et al.
Publicado: (2023) -
Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry
por: Ratnayake, Irushi, et al.
Publicado: (2021) -
Hereditary Endocrine Tumor Registries
por: Moore, Edwina C, et al.
Publicado: (2022) -
Developing a Preliminary Conceptual Framework for Guidelines on Inclusion of Patient Reported-Outcome Measures (PROMs) in Clinical Quality Registries
por: Ruseckaite, Rasa, et al.
Publicado: (2019)